Luke W. Barker

Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics

Romain‐David Seban, John S. Nemer, Aurélien Marabelle et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 123 citations

Cancer Immunosurveillance, Anti-pd1 Immunotherapy, Medicine +8

Emergency department impact following the introduction of an electric scooter sharing service

Sierra Beck, Luke W. Barker, Annie Chan et al. · Emergency Medicine Australasia · 2019 · 108 citations

Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor

Jisu Li, Li Zong, Camille Sureau et al. · Journal of Virology · 2016 · 44 citations · Full text

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Robyn D. Gartrell, Andrew Chen, Emanuelle M. Rizk et al. · Cancer Research · 2020 · 31 citations · Full text

Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II–III Melanoma

Robyn D. Gartrell, Douglas K. Marks, Emanuelle M. Rizk et al. · Clinical Cancer Research · 2019 · 22 citations · Full text